Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin Followed by Pemetrexed and Gemcitabine in Bladder Cancer
NCT00101842Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in bladder cancer, sponsored by Eli Lilly and Company. Started Dec 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00101842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101842.